Enhanced protection by use of a combination of anticapsule antilipopolysaccharide monoclonal antibodies against lethal escherichia coli o18k5 infection of mice

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 775-781

  Frasa, Helma ^a   Benaissa Trouw, Barry ^a   Tavares, Luis ^a   Van Kessel, Kok ^a   Poppelier, Miriam ^a   Kraaijeveld, Kees ^a   Verhoef, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ARTICLE; BACTERIAL INFECTION; CELL PROTECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; LETHALITY; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030038451     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.775-781.1996     Document Type: Article

References (35)

1. Bassoe, C. F., O. D. Laerum, C. S. Solberg, and B. Haneberg. 1983. Phagocytosis of bacteria by human leucocytes measured by flow cytometry. Proc. Soc Exp. Biol. Med. 174:182-186.
2. Cantinieaux, B., P. Hariga, P. Courtoy, J. Hupin, and P. Fondu. 1989. Staphylococcus, aureus phagocytosis, a new cytofluorometric method using FITC and paraformaldehyde J. Immunol Methods 121:203-208.
3. Cross, A. S., P. Gemski, J. C. Sadoff, F. Ørskov, and I. Ørskov. 1984. The importance of the K1 capsule in invasive infections caused by Escherichia coli. J. Infect. Dis. 149:184-193.
4. Cross, A. S., K. S. Kim, D. C. Wright, J. C. Sadoff, and P. Gemski. 1986 Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect. Dis 154:497-503.
5. Cross, A. S., S. M. Opal, J. E. Palardy, M. W. Bodmer, and J. C. Sadoff. 1993. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis. J. Infect. Dis 167:112-118
6. Cross, A. S., S. M. Opal, J. C. Sadoff, and P. Gemski. 1993. Choice of bacteria in animal models of sepsis Infect. Immun 61:2741-2747.
7. Cross, A. S., W. Zollinger, R. Mandrell, P. Gemski, and J. Sadoff. 1983. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli. J. Infect. Dis. 147:68-76.
8. Evans, M. E., M. Pollack, N. J. Hardegen, N. L. Koles, G. Guelde, and J. K. S. Chia. 1990. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria. J Infect. Dis. 162:148-155.
9. Evans, M. E., M. Pollack, N. L. Koles, N. J. Hardegen, and D. Panopoulos. 1992. Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry. J. Infect Dis. 166:803-811
10. Frasa, H., J. Procee, R. Torensma, A. Verbruggen, A. Algra, M. Rozenberg-Arska, K. Kraaijeveld, and J. Verhoef. 1993. Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains J. Clin. Microbiol 31:3174-3178
11. Gant, V. A., G. Warnes, I. Phillips, and G. F. Savidge. 1993. The application of flow cytometry to the study of bacterial responses to antibiotics J. Med. Microbiol 39:147-154
12. Gransden, W. R., S. J. Eykyn, I. Phillips, and B. Rowe. 1990. Bacteremia due to Escherichia coli a study of 861 episodes. Rev. Infect. Dis. 12:1008-1018
13. Greenman, R. L., R. M. H. Schein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, J. Plouffe, J. A. Russell, and the XOMA Sepsis Study Group. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxm in the treatment of gram-negative sepsis. JAMA 266:1097-1102.
14. Gupta, D. S., B. Jann, and K. Jan n. 1984. Escherichia coli OlSac antigen: structure of the O-specific polysaccharide moiety. Infect. Immun. 45:203-209.
15. Jann, B., and K. Jann. 1990. Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr. Top Microbiol. Immunol. 150:19-42.
16. Jann, K., and B. Jann. 1992. Capsules of Escherichia coli, expression and biological significance. Can J. Microbiol. 38:705-710.
17. Kim, K. S., J. H. Kang, A. S. Cross, B. Kaufman, W. Zollinger, and J. Sadoff. 1988. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo. J. Infect Dis. 157: 47-53.
18. McGabe, W. R., B. Kaijser, S. Oiling, M. Uwayday, and LA Hanson. 1978, Escherichia coli in bacteremia. K and O antigens and serum sensitivity of strains from adults and neonates. J. Infect. Dis. 138:33-41.
19. Mitov, I. G., and D. G. Terziiski. 1991. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides. Infection 19:383-390.
20. Nelson, D., W. Neill, and I. R. Poxton. 1990. A comparison of immunoblotting. flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies. J. Immunol. Methods 133:227-233.
21. Pelkonen, S., and G. Pluschke. 1989. Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection Immunology 68: 250-264.
22. Phillips, A. P., and K. L. Martin. 1988. Limitations of flow cytometry for the specific detection of bacteria in mixed populations. J. Immunol. Methods 106:109-117.
23. Pluschke, G., and M. Achtman. 1985. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1. Infect. Immun. 49:365-370
24. Pluschke, G., J. Mayden, M. Achtman, and R. P. Levine. 1983. Role of the capsule and the O antigen in resistance of O18.K1 Escherichia coli to complement-mediated killing. Infect. Immun. 42:907-913.
25. Raff, H. V., C. Bradley, W. Brady, K. Donaldson, L. Lipsich, G. Maloney, W. Shuford, M. Walls, P. Ward, E. Wolff, and L. J. Harris. 1991. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J. Infect. Dis. 163:346-354.
26. Ralph, P., and I. Nakoinz. 1975. Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature (London) 257:393-394.
27. Reed, L. J., and H. A. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
28. Schiff, D. E., C. A. Wass, S. J. Cryz, A. S. Cross, and K. S. Kim. 1993. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection. Infect. Immun. 61:975-980.
29. Sjursen, H. R., R. Bjerknes, A. Halstensen, A. Naess, S. Soraes, and C. O. Solberg. 1989 Flow cytometric assay for the measurement of serum opsonins to Neisseria meningitidis serogroup B, serotype 15. J. Immunol. Methods 116:235-243.
30. Tarleton, R. L., and A. M. Beyer. 1991. Medium-scale production and purification of monoclonal antibodies in protein-free medium. BioTechniques 11:590-593.
31. Torensma, R., M. J. C. Visser, C. J. M. Aarsman, M. J. J. G. Poppelier, R. van Beurden, A. C. Fluit, and J. Verhoef. 1992. Monoclonal antibodies that detect live salmonellae. Appl. Environ Microbiol. 58:3868-3872.
32. Vermeulen, C., A. Cross, W. R. Byrne, and W. Zollinger. 1988. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect. Immun. 56:2723-2730.
33. Wenzel, R. P. 1988. The mortality of hospital-acquired bloodstream infections: need for a new vital statistic. Int. J. Epidemiol. 17:225-227.
34. Wenzel, R. P., V. T. Andriole, J. G. Bartlett, M. D. Batt, W. E. Bullock, C. G. Cobbs, B. Light, M. A. Martin, J. Sanford, and M. A. Sande. 1992. Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA Clin. Infect. Dis. 14:973-976.
35. Ziegler, E. J., C. J. Fisher, C. L. Sprung, R. Straube, J. C. Sadoff, G. E. Foulke, C. H. Wortel, M. P. Fink, R. P. Dellinger, N. N. H. Teng, I. E. Allen, H. J. Berger, G. L. Knatterud, A. F. LoBuglio, C. R. Craig, and the HA-1A Sepsis Study Group. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N. Engl. J. Med. 324:429-436.